Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Lamivudine Oral Solution

Approval Number

国药准字H20183379

Company江苏汉晨药业有限公司

Registration Date

May 5, 2023

Drug Information

Generic Name

拉米夫定口服溶液

Dosage Form

口服溶液剂

Strength

5mg/ml(240ml:1.2g)

Drug Type

化学药品

Registration Date

May 5, 2023

Company Information

Applicant Company

Company Name江苏汉晨药业有限公司

Company Address

江苏省南通市海门区悦来工业区三条桥路188号

Manufacturing Company

Company Name江苏汉晨药业有限公司

Company Address

江苏省南通市海门区悦来工业区三条桥路188号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy